Careful post-marketing surveillance and long-term clinical trials were needed over the following decades to determine whether the drugs prescribed to lower cholesterol levels are actually the ones that trigger cancer in humans. During the research, it was quickly found that these lipid-lowering drugs, particularly statins and fibrates, should not be used in humans or animals, especially in patients at high risk of coronary heart disease.”
